{"id":55410,"date":"2025-07-30T08:41:41","date_gmt":"2025-07-30T08:41:41","guid":{"rendered":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/"},"modified":"2025-07-30T08:41:41","modified_gmt":"2025-07-30T08:41:41","slug":"estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/","title":{"rendered":"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a"},"content":{"rendered":"<p>JOSE CARLOS BEN\u00cdTEZ MONTA\u00d1\u00c9S &#8211; ESTUDIO OBSERVACIONAL CON MEDICAMENTOS &#8211; No aplica &#8211; ASTRAZENECA FARMACEUTICA ESPA\u00d1A S.A.<\/p>","protected":false},"excerpt":{"rendered":"<p>JOSE CARLOS BEN\u00cdTEZ MONTA\u00d1\u00c9S &#8211; ESTUDIO OBSERVACIONAL CON MEDICAMENTOS &#8211; No aplica &#8211; ASTRAZENECA FARMACEUTICA ESPA\u00d1A S.A.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2296],"tags":[],"class_list":["post-55410","post","type-post","status-publish","format-standard","hentry","category-ensayos-clinicos","category-ensayos-clinicos-b-05-ensayos-clinicos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a - Ibima\" \/>\n<meta property=\"og:description\" content=\"JOSE CARLOS BEN\u00cdTEZ MONTA\u00d1\u00c9S &#8211; ESTUDIO OBSERVACIONAL CON MEDICAMENTOS &#8211; No aplica &#8211; ASTRAZENECA FARMACEUTICA ESPA\u00d1A S.A.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T08:41:41+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a\",\"datePublished\":\"2025-07-30T08:41:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/\"},\"wordCount\":57,\"commentCount\":0,\"articleSection\":[\"Ensayos Cl\u00ednicos\",\"Ensayos Cl\u00ednicos - B-05\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/\",\"name\":\"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-07-30T08:41:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/","og_locale":"en_GB","og_type":"article","og_title":"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a - Ibima","og_description":"JOSE CARLOS BEN\u00cdTEZ MONTA\u00d1\u00c9S &#8211; ESTUDIO OBSERVACIONAL CON MEDICAMENTOS &#8211; No aplica &#8211; ASTRAZENECA FARMACEUTICA ESPA\u00d1A S.A.","og_url":"https:\/\/ibima.eu\/en\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/","og_site_name":"Ibima","article_published_time":"2025-07-30T08:41:41+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a","datePublished":"2025-07-30T08:41:41+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/"},"wordCount":57,"commentCount":0,"articleSection":["Ensayos Cl\u00ednicos","Ensayos Cl\u00ednicos - B-05"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/","url":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/","name":"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-07-30T08:41:41+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/estudio-ambispectivo-no-intervencionista-de-cohortes-multiples-para-evaluar-el-manejo-del-tratamiento-con-osimertinib-en-pacientes-con-cancer-de-pulmon-no-microcitico-con-mutaciones-egfr-en-condicio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Estudio ambispectivo, no intervencionista, de cohortes m\u00faltiples para evaluar el manejo del tratamiento con osimertinib en pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico con mutaciones EGFR en condiciones reales en Espa\u00f1a"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/55410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=55410"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/55410\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=55410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=55410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=55410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}